- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
- 20-F Annual report (foreign)
- 2.1 Description of Securities Registered Under Section 12 of the Exchange Act
- 4.1 Asset Purchase Agreement, Dated November 3, 2021, Among Mdweb, LLC, Nano-x Imaging. and Nano-x Imaging LTD
- 4.2 Agreement and Plan of Merger, Dated August 9, 2021, Among Nano-x Imaging LTD, Zebra Medical Vision LTD. and Perryllion LTD
- 4.3 First Amendment to the Agreement and Plan of Merger, Dated August 9, 2021, Among Nano-x Imaging LTD, Zebra Medical Vision LTD. and Perryllion LTD
- 4.4 Stock Purchase Agreement Dated November 2, 2021 by and Among DR. Michael Yuz ,DR. Michael Yuz As the Representative of Sellers, Usarad Holdings, Inc. and Nano-x Imaging LTD
- 8.1 List of Subsidiaries of the Registrant
- 12.1 Certification
- 12.2 Certification
- 13.1 Certification
- 13.2 Certification
- 15.1 Consent of Kesselman & Kesselman, Certified Public Accountants (Isr.) a Member Firm of Pricewaterhousecoopers International Limited, Independent Registered Public Accounting Firm
- Download Excel data file
- View Excel data file
Exhibit 13.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this Annual Report on Form 20-F of Nano-x Imaging Ltd. (the “Company”) for the twelve-months ended December 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Ran Daniel, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: May 2, 2022 | ||
By: | /s/ Erez Meltzer | |
Erez Meltzer | ||
Chief Executive Officer |